Baxter Bros Inc Bausch Health Companies Inc. Transaction History

Baxter Bros Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$7.06 - $23.63 $68,305 - $228,620	-9,675 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$21.6 - $27.79 $25,920 - $33,348	1,200 Added 14.16%	9,675 $221,000
Q2 2021 Aug 11, 2021	SELL	$27.43 - $32.7 $4,114 - $4,905	-150 Reduced 1.74%	8,475 $248,000
Q1 2021 Apr 23, 2021	SELL	$21.37 - $34.38 $42,740 - $68,760	-2,000 Reduced 18.82%	8,625 $274,000
Q3 2020 Nov 05, 2020	SELL	$14.88 - $20.13 $1,116 - $1,509	-75 Reduced 0.7%	10,625 $165,000
Q2 2020 Jul 31, 2020	SELL	$13.31 - $20.51 $26,620 - $41,020	-2,000 Reduced 15.75%	10,700 $196,000
Q1 2020 Apr 17, 2020	SELL	$12.98 - $30.25 $2,596 - $6,050	-200 Reduced 1.55%	12,700 $197,000
Q4 2019 Jan 10, 2020	BUY	$18.89 - $31.89 $243,681 - $411,381	12,900 New	12,900 $386,000
Q4 2019 Jan 09, 2020	SELL	$18.89 - $31.89 $281,461 - $475,161	-14,900 Closed	0 $0
Q4 2018 Jan 22, 2019	SELL	$17.64 - $28.32 $17,640 - $28,320	-1,000 Reduced 6.29%	14,900 $275,000
Q3 2018 Oct 11, 2018	BUY	$20.64 - $25.67 $328,176 - $408,153	15,900 New	15,900 $408,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.72B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

Stay updated on Baxter Bros Inc with notifications on news.